Financial reports
10-Q
2015 Q2
Quarterly report
9 Jun 15
10-Q
2015 Q1
Quarterly report
9 Mar 15
10-K
2014 FY
Annual report
13 Jan 15
10-Q
2014 Q3
Quarterly report
4 Sep 14
10-Q
2014 Q2
Quarterly report
6 Jun 14
ARS
2013 FY
Annual report to shareholders
28 May 14
10-Q
2014 Q1
Quarterly report
10 Mar 14
10-K
2013 FY
Annual report
13 Jan 14
10-Q
2013 Q3
Quarterly report
6 Sep 13
10-Q
2013 Q2
Quarterly report
7 Jun 13
Current reports
8-K
Completion of Acquisition or Disposition of Assets
20 Aug 15
8-K
Other Events
10 Aug 15
8-K
OKPO Health, Inc. and Bio-Reference Laboratories, Inc. Joint Conference Call
11 Jun 15
8-K
Regulation FD Disclosure
10 Jun 15
8-K
OPKO and Bio-Reference Laboratories To Hold Joint Conference Call to Discuss Merger
8 Jun 15
8-K
Bio-reference Laboratories, Inc. Reports Solid Revenues and Earnings for Q2FY15
8 Jun 15
8-K
OPKO Health to Acquire Bio-Reference Laboratories
4 Jun 15
8-K
Entry into a Material Definitive Agreement
20 May 15
8-K
Departure of Directors or Certain Officers
29 Apr 15
8-K
Other Events
13 Mar 15
Registration and prospectus
15-12G
Securities registration termination
31 Aug 15
25-NSE
Exchange delisting
20 Aug 15
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Aug 15
425
Business combination disclosure
19 Aug 15
425
Business combination disclosure
6 Aug 15
425
Business combination disclosure
30 Jul 15
425
Business combination disclosure
2 Jul 15
425
Business combination disclosure
2 Jul 15
425
Business combination disclosure
18 Jun 15
425
Business combination disclosure
11 Jun 15
Proxies
DEFM14A
Proxy related to merger
20 Jul 15
DEF 14A
Definitive proxy
28 May 14
DEF 14A
Definitive proxy
28 May 13
DEF 14A
Definitive proxy
6 Jun 12
DEF 14A
Definitive proxy
1 Aug 11
DEF 14A
Definitive proxy
17 Jun 10
DEF 14A
Definitive proxy
18 Jun 09
DEF 14A
Definitive proxy
16 Jun 08
DEF 14A
Definitive proxy
12 Jun 07
DEF 14A
Definitive proxy
16 Jun 06
Other
UPLOAD
Letter from SEC
18 Jul 11
CORRESP
Correspondence with SEC
7 Jul 11
UPLOAD
Letter from SEC
29 Jun 11
CORRESP
Correspondence with SEC
10 Jun 11
UPLOAD
Letter from SEC
27 May 11
CORRESP
Correspondence with SEC
21 Apr 11
CORRESP
Correspondence with SEC
8 Apr 11
UPLOAD
Letter from SEC
29 Mar 11
UPLOAD
Letter from SEC
13 Feb 09
UPLOAD
Letter from SEC
27 Jan 09
Ownership
4
SAM SINGER
20 Aug 15
4
JOHN ROGLIERI
20 Aug 15
4
HOWARD DUBINETT
20 Aug 15
4
MARC GRODMAN
20 Aug 15
3
Nicholas Papazicos
1 May 15
3
ILAN KAUFTHAL
13 Mar 15
SC 13G/A
Bio Reference Laboratories Inc
12 Feb 15
SC 13G/A
Bio Reference Laboratories Inc
11 Feb 15
SC 13G
Bio Reference Laboratories Inc
4 Feb 15
SC 13G/A
Bio Reference Laboratories Inc
29 Jan 15